IL21 is predominantly produced by a CXCL13 associated CD4+ T cell subset and shapes the immune microenvironment in colorectal cancer

Category	Detail
Condition	Colorectal Cancer
Key Mechanisms	IL21 production by CXCL13-associated CD4+ T cells influences the immune microenvironment.
Target Population	Patients with colorectal cancer, particularly those with microsatellite-stable disease.
Care Setting	Oncology and immunotherapy research.

IL21 is predominantly expressed in CXCL13+CD4+ T cell populations in colorectal cancer.
Tissue-level analysis shows increased IL21 and IL21+CD4+ T cells in tumor tissues compared to normal tissues.
Correlation analysis indicates a positive association between IL21 expression and various CD4+ T cell subsets.
Exogenous IL21 induces transcriptional changes in murine colorectal tumor tissues, activating immune pathways.
SCENIC analysis identifies key transcription factors associated with CXCL13-associated CD4+ T cell subsets.

Utilize single-cell RNA sequencing to characterize immune cell populations in colorectal cancer.

Consider the role of IL21 in shaping the immune microenvironment when developing immunotherapy strategies.

Assess IL21 levels and associated CD4+ T cell populations in tumor microenvironments.

Patients with microsatellite-stable colorectal cancer may derive limited benefit from current immune checkpoint inhibitors.

Patients with colorectal cancer, especially those with microsatellite-stable disease.

IL21 may serve as a potential target for enhancing antitumor immunity in colorectal cancer.

Integrate single-cell technologies to evaluate T cell diversity in colorectal cancer.
Focus on the functional roles of specialized CD4+ T cell subsets in the tumor microenvironment.

Clinical Scorecard: A CD4+ T cell subset associated with CXCL13 is the primary source of IL21, influencing the immune microenvironment in colorectal cancer